A Case of Tenosynovial Giant Cell Tumor, Localized Type of the Temporomandibular Joint

A diffuse-type tenosynovial giant cell tumor is a benign bone and soft tissue tumor arising from the joint synovium or tendon sheath, and is a subclass of tenosynovial giant cell tumors. It occurs mainly in large joints such as the knee joint, and occurs rarely in the temporomandibular joint. In thi...

Full description

Saved in:
Bibliographic Details
Published inJIBI INKOKA TEMBO Vol. 66; no. 5; pp. 217 - 223
Main Authors Shiraki, Yuichiro, Nagaoka, Masato, Kawasaki, Takeshi, Kobayashi, Toshiki, Yui, Ryosuke
Format Journal Article
LanguageJapanese
Published Society of Oto-rhino-laryngology Tokyo 15.10.2023
耳鼻咽喉科展望会
Subjects
Online AccessGet full text
ISSN0386-9687
1883-6429
DOI10.11453/orltokyo.66.5_217

Cover

Abstract A diffuse-type tenosynovial giant cell tumor is a benign bone and soft tissue tumor arising from the joint synovium or tendon sheath, and is a subclass of tenosynovial giant cell tumors. It occurs mainly in large joints such as the knee joint, and occurs rarely in the temporomandibular joint. In this case, a patient visited a previous doctor with the chief complaints of left temporomandibular joint pain, trismus, and headache. Giant cell reparative granuloma was suspected based upon CT-guided biopsy, and she was referred to our hospital for treatment. Imaging tests were also performed at our hospital, but no definitive diagnosis was made. An initial surgical resection was performed for the purpose of diagnosis and treatment, and the pathological results and site of origin led to the diagnosis of diffuse-type tenosynovial giant cell tumor. Recurrence of the headache was subsequently observed, and it was thought to be due to residual lesions. Although there was a possibility that postoperative functional impairment remained, from the viewpoint of local control, a second surgical excision was performed using wide excision. The recurrence rate of giant cell reparative granuloma is 10–17% after sufficient curettage and resection of the lesion, but diffuse-type tenosynovial giant cell tumor has a high recurrence rate of 25–46%. Wide excision is preferable from the perspective of local control, although there remains the possibility that later functional impairment may occur.
AbstractList A diffuse-type tenosynovial giant cell tumor is a benign bone and soft tissue tumor arising from the joint synovium or tendon sheath, and is a subclass of tenosynovial giant cell tumors. It occurs mainly in large joints such as the knee joint, and occurs rarely in the temporomandibular joint. In this case, a patient visited a previous doctor with the chief complaints of left temporomandibular joint pain, trismus, and headache. Giant cell reparative granuloma was suspected based upon CT-guided biopsy, and she was referred to our hospital for treatment. Imaging tests were also performed at our hospital, but no definitive diagnosis was made. An initial surgical resection was performed for the purpose of diagnosis and treatment, and the pathological results and site of origin led to the diagnosis of diffuse-type tenosynovial giant cell tumor. Recurrence of the headache was subsequently observed, and it was thought to be due to residual lesions. Although there was a possibility that postoperative functional impairment remained, from the viewpoint of local control, a second surgical excision was performed using wide excision. The recurrence rate of giant cell reparative granuloma is 10–17% after sufficient curettage and resection of the lesion, but diffuse-type tenosynovial giant cell tumor has a high recurrence rate of 25–46%. Wide excision is preferable from the perspective of local control, although there remains the possibility that later functional impairment may occur.
A diffuse-type tenosynovial giant cell tumor is a benign bone and soft tissue tumor arising from the joint synovium or tendon sheath, and is a subclass of tenosynovial giant cell tumors. It occurs mainly in large joints such as the knee joint, and occurs rarely in the temporomandibular joint. In this case, a patient visited a previous doctor with the chief complaints of left temporomandibular joint pain, trismus, and headache. Giant cell reparative granuloma was suspected based upon CT-guided biopsy, and she was referred to our hospital for treatment. Imaging tests were also performed at our hospital, but no definitive diagnosis was made. An initial surgical resection was performed for the purpose of diagnosis and treatment, and the pathological results and site of origin led to the diagnosis of diffuse-type tenosynovial giant cell tumor. Recurrence of the headache was subsequently observed, and it was thought to be due to residual lesions. Although there was a possibility that postoperative functional impairment remained, from the viewpoint of local control, a second surgical excision was performed using wide excision. The recurrence rate of giant cell reparative granuloma is 10–17% after sufficient curettage and resection of the lesion, but diffuse-type tenosynovial giant cell tumor has a high recurrence rate of 25–46%. Wide excision is preferable from the perspective of local control, although there remains the possibility that later functional impairment may occur. びまん型腱滑膜巨細胞腫は,関節滑膜や腱鞘から発生する良性骨軟部腫瘍であり,腱滑膜巨細胞腫の亜分類である.主に膝関節などの大関節に発生し,顎関節に発生することは極めて稀とされている.今回経験した症例は,左顎関節痛,開口障害,頭痛を主訴に前医を受診し,頭頸部CT検査において左顎関節部腫瘤を指摘された.CTガイド下生検において巨細胞修復性肉芽腫が疑われ,治療目的で当院に紹介となった.当院においても画像検査を行ったが,確定診断には至らなかった.診断および治療目的に初回の外科的切除を行い,病理結果と発生部位よりびまん型腱滑膜巨細胞腫の診断となった.その後,頭痛の再燃を認め,残存病変によるものと考え,術後の機能障害が残存する可能性はあるものの局所制御の観点から広範切除術を用いた2回目の外科的切除を行なった.巨細胞修復性肉芽腫は病変の十分な掻爬術や摘出術によって再発率は10~17%とされているが,びまん型腱滑膜巨細胞腫は再発率が25~46%と高く,術後の機能障害が残存する可能性はあるものの局所制御の観点から広範切除が望ましいと考えた.
Author Yui, Ryosuke
Nagaoka, Masato
Shiraki, Yuichiro
Kobayashi, Toshiki
Kawasaki, Takeshi
Author_FL 小林 俊樹
由井 亮輔
長岡 真人
MD Shiraki Yuichiro
川崎 健史
Author_FL_xml – sequence: 1
  fullname: 川崎 健史
– sequence: 2
  fullname: MD Shiraki Yuichiro
– sequence: 3
  fullname: 由井 亮輔
– sequence: 4
  fullname: 長岡 真人
– sequence: 5
  fullname: 小林 俊樹
Author_xml – sequence: 1
  fullname: Shiraki, Yuichiro
  organization: Department of Otolaryngology, The Jikei University School of Medicine
– sequence: 1
  fullname: Nagaoka, Masato
  organization: Department of Otolaryngology, The Jikei University School of Medicine
– sequence: 1
  fullname: Kawasaki, Takeshi
  organization: Department of Otolaryngology, The Jikei University School of Medicine
– sequence: 1
  fullname: Kobayashi, Toshiki
  organization: Department of Otolaryngology, Head and Neck Surgery, The Jikei University Kashiwa Hospital
– sequence: 1
  fullname: Yui, Ryosuke
  organization: Department of Otolaryngology, The Jikei University School of Medicine
BackLink https://cir.nii.ac.jp/crid/1390301839610328704$$DView record in CiNii
BookMark eNo9UL1OwzAYtFCRKKUvwOSBkRQ7dmxnLBEUUCWWiNVynK_UJbErJ0UKT09KgeVuuB-d7hJNfPCA0DUlC0p5xu5CbPrwMYSFEItMp1SeoSlViiWCp_kETQlTIsmFkhdo3nWuIiRTMhdCTtHbEhemAxw2uAQfusGHT2cavHLG97iApsHloQ3xFq-DNY37ghqXw_4n0G9hDLX7EENrfO2qQ2MifgnO91fofGOaDua_PEPl40NZPCXr19VzsVwnO6V4AlzmtLY2B7UhkjFqU16BzMbVtOZGAKukYlXOrbB1WluVSgvc1tQCgLSGzdDNqdY7p607ImU5YYQqlgtKWKok4aPt_mTbdb15B72PrjVx0Cb2zjag__7TQujsCOOF_6LdmqjBs29Ky27V
ContentType Journal Article
Copyright 2023 Society of Oto-rhino-laryngology Tokyo
Copyright_xml – notice: 2023 Society of Oto-rhino-laryngology Tokyo
DBID RYH
DOI 10.11453/orltokyo.66.5_217
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 顎関節に生じたびまん型腱滑膜巨細胞腫の1例
DocumentTitle_FL 顎関節に生じたびまん型腱滑膜巨細胞腫の1例
EISSN 1883-6429
EndPage 223
ExternalDocumentID article_orltokyo_66_5_66_217_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
OK1
RJT
RYH
ID FETCH-LOGICAL-j884-e4791dcc9e8f07331c24be754291d4a6e3b783b94c6cd2dc827ce4cd1ceee7ca3
ISSN 0386-9687
IngestDate Thu Jun 26 22:06:14 EDT 2025
Wed Sep 03 06:30:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 5
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j884-e4791dcc9e8f07331c24be754291d4a6e3b783b94c6cd2dc827ce4cd1ceee7ca3
OpenAccessLink https://www.jstage.jst.go.jp/article/orltokyo/66/5/66_217/_article/-char/en
PageCount 7
ParticipantIDs nii_cinii_1390301839610328704
jstage_primary_article_orltokyo_66_5_66_217_article_char_en
PublicationCentury 2000
PublicationDate 2023/10/15
2023-10-15
PublicationDateYYYYMMDD 2023-10-15
PublicationDate_xml – month: 10
  year: 2023
  text: 2023/10/15
  day: 15
PublicationDecade 2020
PublicationTitle JIBI INKOKA TEMBO
PublicationTitleAlternate O.R.L.Tokyo
PublicationTitle_FL OTO-RHINO-LARYNGOLOGY, TOKYO
耳鼻咽喉科展望
ORL, Tokyo
O.R.L.Tokyo
OTO-RHINO-LARYNGOLOGY,TOKYO
耳展
PublicationYear 2023
Publisher Society of Oto-rhino-laryngology Tokyo
耳鼻咽喉科展望会
Publisher_xml – name: Society of Oto-rhino-laryngology Tokyo
– name: 耳鼻咽喉科展望会
References 3) 梅林芳弘:皮膚科セミナリウム第32回分かりやすい皮膚良性腫瘍.日皮誌 117: 2461–2469, 2007.
5) John SC, Melinda AM, Kelli DM, et al: Translocation and expression of CSF1 inpigmentedvillonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol 31: 970–976, 2007.
1) De Saint Aubain N, Van Rijin M: Tenosynovial giant cell tumour, localized type. WHO Classification of Tumours of Soft Tissue and Bone Tumours (5 th ed.), Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds): WHO, IARC Press, Lyon, 2013, 133–138.
6) Mastboom MJL, Verspoor FGM, Verschoor AJ, et al: Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop 88: 688–694, 2017.
11) John RG, Sharon WW: Tenosynovial giant cell tumor diffuse type. Soft Tissue Tumors 5th ed., Weiss SW, Goldblum JR (eds): Mosby Press, Saint Louis, 2001, 1047–1054.
7) 甲斐裕基,岡元信和,佐藤広生,他:痛風結節を伴った膝関節内の限局型腱滑膜巨細胞腫の1例.整外と災外 66: 529–533, 2017.
15) Gelderblom H, Wagner AJ, Tap WD, et al: Long-term outcomes of pexidartinib in tenosynovial giant cell tumors. Cancer 127: 884–893, 2021.
9) 石橋 利,清水正嗣,石橋克禮,他:顎関節突起部に発生した骨腫および骨軟骨腫.日口腔科会誌 33: 607–620, 1984.
10) 野島孝之,角田優子:腫瘍病理鑑別診断アトラス 骨腫瘍 第2版,小田義直,吉田朗彦 編:文光堂,東京,2021, 99–101, 165–169.
12) Anwar B, Taiseer A, Ma’amon AR: The surgical treatment of giant cell granuloma of the mandible. J Oral Maxillofac Surg 60: 756–761, 2002.
8) 佐々 航,三又義訓,多田広志,他:臀部に発生した腱滑膜巨細胞腫の1例.東日整災外会誌 32: 546–549, 2020.
14) Tap WD, Gelderblom H, Palmerini E, et al: Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Lancet 394: 478–487, 2019.
4) West RB, Rubin BP, Melinda AM, et al: A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumorcells. Proc Natl Acad Sci USA 103: 690–695, 2006.
13) Minić A, Stajcić Z: Prognostic significance of cortical perforation in the recurence of central giant cell granulomas of the jaws. J Craniomaxillofac Surg 24: 104–108, 1996.
2) Bredell M, Schucknecht B, Bode-Lesniewska B: Tenosynovial, diffuse type giant cell tumor of the temporomandibular joint, diagnosis and management of a rare tumor. J Clin Med Res 7: 262–266, 2015.
References_xml – reference: 3) 梅林芳弘:皮膚科セミナリウム第32回分かりやすい皮膚良性腫瘍.日皮誌 117: 2461–2469, 2007.
– reference: 12) Anwar B, Taiseer A, Ma’amon AR: The surgical treatment of giant cell granuloma of the mandible. J Oral Maxillofac Surg 60: 756–761, 2002.
– reference: 4) West RB, Rubin BP, Melinda AM, et al: A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumorcells. Proc Natl Acad Sci USA 103: 690–695, 2006.
– reference: 11) John RG, Sharon WW: Tenosynovial giant cell tumor diffuse type. Soft Tissue Tumors 5th ed., Weiss SW, Goldblum JR (eds): Mosby Press, Saint Louis, 2001, 1047–1054.
– reference: 13) Minić A, Stajcić Z: Prognostic significance of cortical perforation in the recurence of central giant cell granulomas of the jaws. J Craniomaxillofac Surg 24: 104–108, 1996.
– reference: 6) Mastboom MJL, Verspoor FGM, Verschoor AJ, et al: Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop 88: 688–694, 2017.
– reference: 14) Tap WD, Gelderblom H, Palmerini E, et al: Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Lancet 394: 478–487, 2019.
– reference: 5) John SC, Melinda AM, Kelli DM, et al: Translocation and expression of CSF1 inpigmentedvillonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol 31: 970–976, 2007.
– reference: 10) 野島孝之,角田優子:腫瘍病理鑑別診断アトラス 骨腫瘍 第2版,小田義直,吉田朗彦 編:文光堂,東京,2021, 99–101, 165–169.
– reference: 15) Gelderblom H, Wagner AJ, Tap WD, et al: Long-term outcomes of pexidartinib in tenosynovial giant cell tumors. Cancer 127: 884–893, 2021.
– reference: 9) 石橋 利,清水正嗣,石橋克禮,他:顎関節突起部に発生した骨腫および骨軟骨腫.日口腔科会誌 33: 607–620, 1984.
– reference: 2) Bredell M, Schucknecht B, Bode-Lesniewska B: Tenosynovial, diffuse type giant cell tumor of the temporomandibular joint, diagnosis and management of a rare tumor. J Clin Med Res 7: 262–266, 2015.
– reference: 8) 佐々 航,三又義訓,多田広志,他:臀部に発生した腱滑膜巨細胞腫の1例.東日整災外会誌 32: 546–549, 2020.
– reference: 1) De Saint Aubain N, Van Rijin M: Tenosynovial giant cell tumour, localized type. WHO Classification of Tumours of Soft Tissue and Bone Tumours (5 th ed.), Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds): WHO, IARC Press, Lyon, 2013, 133–138.
– reference: 7) 甲斐裕基,岡元信和,佐藤広生,他:痛風結節を伴った膝関節内の限局型腱滑膜巨細胞腫の1例.整外と災外 66: 529–533, 2017.
SSID ssib005879667
ssib005902162
ssib005879668
ssib058493089
ssib029852170
ssj0066717
ssib007484760
ssib002004161
Score 2.369026
Snippet A diffuse-type tenosynovial giant cell tumor is a benign bone and soft tissue tumor arising from the joint synovium or tendon sheath, and is a subclass of...
SourceID nii
jstage
SourceType Publisher
StartPage 217
SubjectTerms temporomandibular joint tumor
tenosynovial giant cell tumour
wide excision
びまん型腱滑膜巨細胞腫
広範切除
顎関節腫瘍
Title A Case of Tenosynovial Giant Cell Tumor, Localized Type of the Temporomandibular Joint
URI https://www.jstage.jst.go.jp/article/orltokyo/66/5/66_217/_article/-char/en
https://cir.nii.ac.jp/crid/1390301839610328704
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX JIBI INKOKA TEMBO, 2023/10/15, Vol.66(5), pp.217-223
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1883-6429
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib007484760
  issn: 0386-9687
  databaseCode: KQ8
  dateStart: 19580101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa68cILAgFijKE8kKeQkSZuYountgusLdsECmg8RY7jbmlZjNoU1P0L_jHnJL14DInLy1FrK4nj88XnonMh5EUosnbme8rlAVUuBZHgsrbMXUnbTEnq5R7HfOeT0_D4Ix2ed85brR9G1NKiyg7l9W_zSv6HqzAGfMUs2X_g7OamMAC_gb9AgcNA_4rHXacvGl98gjW_l6X-hg7wt8DyyumjVy5ZXDX2-DuUWcU1qJdoea4jA5K6MJW-wtyWrA5IHeqivOGuHw56A2dwOjobdZ0kPumdbVh05IzEdzEHFdRJxFTNL4v1lB1HNud278iOQ5v37S5z7JjbvGczasfU7jEMsIARFtgsNm74eVE4H5Z6vpgqY_RUXAg9Fc4JPKzSpp_CryPemkzNxk-5CkKF9zurtDu7LErtwnsty4um2FSip0ttnH4BC10erqSxak5nxgIXDCZuHt9N05YVTDs3zuLIEOt-k9Z8W2LQuu-Hnn2pcAGHYXjYSeHSHXLHB0GB3UBG7w2LDAuUGanAHRaBwRj98t-okMZBiTIqMmLp1mhrkfqcgf60PTJBHeSBhw0AGmUCbl03jd7sxjrvC1b96taaQYuagE2BxSJ2yqIwFKXkPrm3snCsbgPXB6Q1EQ_Jp66FULX02DKhatVQtRCqVg3Vl9YGqBYCFS8AoFq3gGrVQH1Ekjdx0j92Vy093Alj1FU04u1cSq7YuO4WKn2aKWzCDMNUhCrIIhZknMpQ5n4umR9JRWXeBlVORVIEj8luqUv1hFjjDAWGBzQQtAPEk7mIeJ7nYMD4XOyR181epF-bsi3p6jNN19uWhmHaQQI7t5nEXEc4WvbIAWxgKgukYCSh4wBMibAuPxl59Okf5vfJ3e038IzsVrOFOgDttcqe13j6CSK-id4
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Case+of+Tenosynovial+Giant+Cell+Tumor%2C+Localized+Type+of+the+Temporomandibular+Joint&rft.jtitle=JIBI+INKOKA+TEMBO&rft.au=MD+Kawasaki+Takeshi&rft.au=%E7%99%BD%E6%9C%A8+%E9%9B%84%E4%B8%80%E9%83%8E&rft.au=MD+Yui+Ryosuke&rft.au=MD+Nagaoka+Masato&rft.date=2023-10-15&rft.pub=Society+of+Oto-rhino-laryngology+Tokyo&rft.issn=0386-9687&rft.eissn=1883-6429&rft.volume=66&rft.issue=5&rft.spage=217&rft.epage=223&rft_id=info:doi/10.11453%2Forltokyo.66.5_217
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-9687&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-9687&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-9687&client=summon